Targets — browse / sort / filter (view)
Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target
- id
- UniProt accession (human). Links to uniprot.org.
- gene_symbol
- Gene symbol (e.g. ITGB3).
- protein_name
- Protein name (UniProt).
- tier
- Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
- priority_score
- Composite prioritisation = 0.30*biology + 0.30*reagent-gap + 0.20*druggability + 0.10*disease + 0.10*novelty. Sub-scores are assigned during LLM-assisted curation — a heuristic ranking, NOT an experimental measurement.
- has_activation_state_pdb_pair
- 1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
- in_cev_map
- 1 if in the EV-Map circulating-EV proteome (Rai 2025); 3,422 targets.
- has_known_aptamer
- 1 if aptamer evidence found in PubMed/Aptagen (1,472 targets).
- opentargets_top_disease_score
- Open Targets association score (0-1).
- aptamer_count_pubmed
- Number of PubMed hits for this protein AND (aptamer OR SELEX).
- aptamer_pmids
- The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
2,076 rows where has_cryoEM = 0, in_cev_map = 0 and tier = "Tier 1.5" sorted by priority_score descending
This data as json, CSV (advanced)
Suggested facets: pdb_count_total
tier 1
- Tier 1.5 · 2,076 ✖
in_cev_map 1
- - · 2,076 ✖
has_cryoEM 1
- - · 2,076 ✖
has_activation_state_pdb_pair 1
- 0 2,076
| id | gene_symbol | protein_name | tier | priority_score ▲ | pdb_count_total | alphafold_mean_pLDDT | has_cryoEM | has_activation_state_pdb_pair | activation_state_pdb_active | activation_state_pdb_inactive | drug_count_approved | has_known_aptamer | aptamer_count_pubmed | aptamer_pmids | in_cev_map | opentargets_top_disease_name | opentargets_top_disease_score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Q9Y2C5 | SLC17A4 | Probable small intestine urate exporter | Tier 1.5 | 0.878 | 0 | 83.69 | 0 | 0 | 0 | 0 | 0 | inflammatory bowel disease | 0.09896486250497885 | ||||
| P0DPK4 | NOTCH2NLC | Notch homolog 2 N-terminal-like protein C | Tier 1.5 | 0.805 | 0 | 80.81 | 0 | 0 | 0 | 0 | 0 | neuronal intranuclear inclusion disease | 0.4999829066911242 | ||||
| Q14031 | COL4A6 | Collagen alpha-6(IV) chain | Tier 1.5 | 0.79 | 0 | 47.41 | 0 | 0 | 0 | 0 | 0 | Dupuytren Contracture | 0.5880367459451578 | ||||
| P37023 | ACVRL1 | Activin receptor type-1-like | Tier 1.5 | 0.779 | 7 | 82.0 | 0 | 0 | 0 | 0 | 0 | telangiectasia, hereditary hemorrhagic, type 2 | 0.7951167515831324 | ||||
| P01568 | IFNA21 | Interferon alpha-21 | Tier 1.5 | 0.777 | 0 | 85.0 | 0 | 0 | 0 | 0 | 0 | renal cell carcinoma | 0.3695798546847018 | ||||
| P48023 | FASLG | Tumor necrosis factor ligand superfamily member 6 | Tier 1.5 | 0.775 | 3 | 80.19 | 0 | 0 | 1 | 1 | 16581027 | 0 | autoimmune lymphoproliferative syndrome type 1 | 0.6984292519156657 | |||
| Q9BVX2 | TMEM106C | Transmembrane protein 106C | Tier 1.5 | 0.77 | 0 | 80.81 | 0 | 0 | 0 | 0 | 0 | prostate carcinoma | 0.21737104399686757 | ||||
| P29017 | CD1C | T-cell surface glycoprotein CD1c | Tier 1.5 | 0.77 | 10 | 88.56 | 0 | 0 | 0 | 0 | 0 | neoplasm | 0.1106047389635713 | ||||
| A0A1B0GTW7 | CIROP | Ciliated left-right organizer metallopeptidase | Tier 1.5 | 0.764 | 0 | 73.44 | 0 | 0 | 0 | 0 | 0 | heterotaxy, visceral, 12, autosomal | 0.6929422132808513 | ||||
| Q9BZR8 | BCL2L14 | Apoptosis facilitator Bcl-2-like protein 14 | Tier 1.5 | 0.76 | 0 | 62.38 | 0 | 0 | 0 | 0 | 0 | hypothyroidism | 0.33117514363294837 | ||||
| Q9BWF2 | TRAIP | E3 ubiquitin-protein ligase TRAIP | Tier 1.5 | 0.76 | 1 | 74.94 | 0 | 0 | 0 | 0 | 0 | Seckel syndrome 9 | 0.683878095944948 | ||||
| O15370 | SOX12 | Transcription factor SOX-12 | Tier 1.5 | 0.76 | 0 | 63.0 | 0 | 0 | 0 | 0 | 0 | type 2 diabetes mellitus | 0.3277369133971199 | ||||
| A6NI61 | MYMK | Protein myomaker | Tier 1.5 | 0.758 | 0 | 90.44 | 0 | 0 | 0 | 0 | 0 | Carey-Fineman-Ziter syndrome | 0.7790386256350393 | ||||
| Q16585 | SGCB | Beta-sarcoglycan | Tier 1.5 | 0.75 | 0 | 76.44 | 0 | 0 | 0 | 0 | 0 | autosomal recessive limb-girdle muscular dystrophy type 2E | 0.8154766151472349 | ||||
| Q9GZU2 | PEG3 | Paternally-expressed gene 3 protein | Tier 1.5 | 0.75 | 1 | 44.53 | 0 | 0 | 1 | 1 | 16595502 | 0 | neurodegenerative disease | 0.34815912577489827 | |||
| P18075 | BMP7 | Bone morphogenetic protein 7 | Tier 1.5 | 0.749 | 4 | 76.19 | 0 | 0 | 1 | 1 | 30537181 | 0 | Inguinal hernia | 0.4420059023371716 | |||
| P56730 | PRSS12 | Neurotrypsin | Tier 1.5 | 0.746 | 0 | 77.31 | 0 | 0 | 0 | 0 | 0 | intellectual disability, autosomal recessive 1 | 0.6621935416695687 | ||||
| Q8N6D2 | RNF182 | E3 ubiquitin-protein ligase RNF182 | Tier 1.5 | 0.74 | 0 | 70.25 | 0 | 0 | 0 | 0 | 0 | periapical tissue disease | 0.304701328693288 | ||||
| Q14246 | ADGRE1 | Adhesion G protein-coupled receptor E1 | Tier 1.5 | 0.74 | 0 | 76.69 | 0 | 0 | 0 | 0 | 0 | diabetic ketoacidosis | 0.20424823130055986 | ||||
| P16112 | ACAN | Aggrecan core protein | Tier 1.5 | 0.74 | 4 | 51.91 | 0 | 0 | 0 | 0 | 0 | Familial osteochondritis dissecans | 0.7558487616449627 | ||||
| Q00LT1 | PRCD | Photoreceptor disk component PRCD | Tier 1.5 | 0.737 | 0 | 63.97 | 0 | 0 | 0 | 0 | 0 | retinitis pigmentosa | 0.7650522818524582 | ||||
| Q9Y4U1 | MMACHC | Cyanocobalamin reductase / alkylcobalamin dealkylase | Tier 1.5 | 0.735 | 7 | 85.62 | 0 | 0 | 0 | 0 | 0 | Methylmalonic acidemia with homocystinuria, type cblC | 0.8478185420804271 | ||||
| Q9ULX7 | CA14 | Carbonic anhydrase 14 | Tier 1.5 | 0.734 | 2 | 90.69 | 0 | 0 | 0 | 0 | 0 | epilepsy | 0.4397024990575866 | ||||
| Q99593 | TBX5 | T-box transcription factor TBX5 | Tier 1.5 | 0.733 | 4 | 62.66 | 0 | 0 | 0 | 0 | 0 | Holt-Oram syndrome | 0.827317913681364 | ||||
| P53539 | FOSB | Protein FosB | Tier 1.5 | 0.73 | 12 | 59.12 | 0 | 0 | 0 | 0 | 0 | neurodegenerative disease | 0.22246010664492422 | ||||
| O43914 | TYROBP | TYRO protein tyrosine kinase-binding protein | Tier 1.5 | 0.728 | 5 | 64.62 | 0 | 0 | 0 | 0 | 0 | Nasu-Hakola disease | 0.7323368313860329 | ||||
| Q9Y5C1 | ANGPTL3 | Angiopoietin-related protein 3 | Tier 1.5 | 0.727 | 1 | 79.62 | 0 | 0 | 1 | 1 | 23770039 | 0 | familial hypobetalipoproteinemia 2 | 0.6739043862507132 | |||
| Q6MZM0 | HEPHL1 | Ferroxidase HEPHL1 | Tier 1.5 | 0.72 | 0 | 89.44 | 0 | 0 | 0 | 0 | 0 | pili torti-developmental delay-neurological abnormalities syndrome | 0.40268634456935765 | ||||
| Q15399 | TLR1 | Toll-like receptor 1 | Tier 1.5 | 0.72 | 6 | 87.19 | 0 | 0 | 0 | 0 | 0 | asthma | 0.5956884825296496 | ||||
| Q9NWH7 | SPATA6 | Spermatogenesis-associated protein 6 | Tier 1.5 | 0.72 | 0 | 65.19 | 0 | 0 | 0 | 0 | 0 | hypothyroidism | 0.4205896274474635 | ||||
| P25100 | ADRA1D | Alpha-1D adrenergic receptor | Tier 1.5 | 0.716 | 0 | 64.81 | 0 | 0 | 0 | 0 | 0 | hypertension | 0.6613200073424285 | ||||
| O60882 | Tier 1.5 | 0.713 | 1 | 83.31 | 0 | 0 | 0 | 0 | 0 | Hypomaturation amelogenesis imperfecta | 0.7281006394540224 | ||||||
| Q8N9I5 | FADS6 | Fatty acid desaturase 6 | Tier 1.5 | 0.71 | 0 | 90.62 | 0 | 0 | 0 | 0 | 0 | ||||||
| P30968 | GNRHR | Gonadotropin-releasing hormone receptor | Tier 1.5 | 0.71 | 1 | 84.19 | 0 | 0 | 0 | 0 | 0 | hypogonadotropic hypogonadism | 0.83100005285263 | ||||
| Q9H2B4 | SLC26A1 | Sulfate anion transporter 1 | Tier 1.5 | 0.707 | 0 | 82.62 | 0 | 0 | 0 | 0 | 0 | nephrolithiasis susceptibility caused by SLC26A1 | 0.6690419713525324 | ||||
| P08620 | FGF4 | Fibroblast growth factor 4 | Tier 1.5 | 0.7 | 1 | 81.5 | 0 | 0 | 1 | 3 | 35415885, 33536494, 7547864 | 0 | cancer | 0.6026669167438079 | |||
| O95886 | DLGAP3 | Disks large-associated protein 3 | Tier 1.5 | 0.7 | 0 | 50.16 | 0 | 0 | 0 | 0 | 0 | benign neoplasm of adrenal gland | 0.3188339358953556 | ||||
| A0A0C5B5G6 | MT-RNR1 | Mitochondrial-derived peptide MOTS-c | Tier 1.5 | 0.7 | 0 | 72.06 | 0 | 0 | 1 | 1 | 35311942 | 0 | |||||
| Q96LB9 | PGLYRP3 | Peptidoglycan recognition protein 3 | Tier 1.5 | 0.699 | 4 | 88.12 | 0 | 0 | 0 | 0 | 0 | Romano-Ward syndrome | 0.08833005834552343 | ||||
| Q01814 | ATP2B2 | Plasma membrane calcium-transporting ATPase 2 | Tier 1.5 | 0.696 | 0 | 73.38 | 0 | 0 | 0 | 0 | 0 | autosomal dominant nonsyndromic hearing loss | 0.6637167639130592 | ||||
| Q16676 | FOXD1 | Forkhead box protein D1 | Tier 1.5 | 0.695 | 0 | 56.75 | 0 | 0 | 0 | 0 | 0 | neurodegenerative disease | 0.45840779990331637 | ||||
| P21781 | FGF7 | Fibroblast growth factor 7 | Tier 1.5 | 0.695 | 0 | 82.44 | 0 | 0 | 1 | 5 | 35415885, 15719578, 7547864, 16462265 | 0 | cancer | 0.5963369026823151 | |||
| P49895 | DIO1 | Type I iodothyronine deiodinase | Tier 1.5 | 0.695 | 0 | 92.12 | 0 | 0 | 0 | 0 | 0 | thyroid hormone metabolism, abnormal, 2 | 0.6505024812924749 | ||||
| P28039 | AOAH | Acyloxyacyl hydrolase | Tier 1.5 | 0.695 | 2 | 90.38 | 0 | 0 | 0 | 0 | 0 | type 2 diabetes mellitus | 0.4486206035972812 | ||||
| O00337 | SLC28A1 | Sodium/nucleoside cotransporter 1 | Tier 1.5 | 0.695 | 0 | 82.25 | 0 | 0 | 0 | 0 | 0 | uridine-cytidineuria | 0.5835072752618243 | ||||
| Q9UPX6 | MINAR1 | Major intrinsically disordered Notch2-binding receptor 1 | Tier 1.5 | 0.69 | 0 | 49.62 | 0 | 0 | 0 | 0 | 0 | Hypercholesterolemia | 0.32960705987096356 | ||||
| P35712 | SOX6 | Transcription factor SOX-6 | Tier 1.5 | 0.69 | 0 | 55.25 | 0 | 0 | 0 | 0 | 0 | Tolchin-Le Caignec syndrome | 0.7327592361597494 | ||||
| P10243 | MYBL1 | Myb-related protein A | Tier 1.5 | 0.687 | 0 | 57.31 | 0 | 0 | 0 | 0 | 0 | neurodegenerative disease | 0.5225910891181897 | ||||
| P01570 | IFNA14 | Interferon alpha-14 | Tier 1.5 | 0.687 | 0 | 84.62 | 0 | 0 | 0 | 0 | 0 | renal cell carcinoma | 0.3695798546847018 | ||||
| O00624 | SLC17A2 | Sodium-dependent phosphate transport protein 3 | Tier 1.5 | 0.687 | 0 | 83.12 | 0 | 0 | 0 | 0 | 0 | Fuchs endothelial corneal dystrophy | 0.07320524268733301 |
Advanced export
JSON shape: default, array, newline-delimited
CREATE VIEW v_targets AS SELECT f.id, n.gene_symbol, n.protein_name, tg.tier, f.priority_score, f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM, f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive, f.drug_count_approved, f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids, f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score FROM v_target_full f LEFT JOIN target_names n ON n.target_id=f.id LEFT JOIN targets tg ON tg.id=f.id LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id;